Wall Street opens lower amid Russia probe, Fed pick
October 30, 2017Apple touches record as brokerages bullish on iPhone X demand
October 30, 2017Cancer-drug setback sends Merck shares down again
at
NEW YORK (Reuters) – A setback for Merck & Co’s key cancer drug sent the drugmaker’s stock swooning on Monday for a second straight session, putting the shares on track for their biggest two-day decline in more than eight years.
Powered by WPeMatico
